J. Zimmermann - Concepedia

Author

J. Zimmermann

Also Known As

J Zimmermann, J. P. ZIMMERMANN, J. P. Zimmermann, J. ZIMMERMANN, J. Zimmermann, Joel Zimmermann, Jurg Zimmermann, Jürg Zimmermann, Jürg Zimmermann, Zimmermann, Jürg

108

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Scripps Research Institute University of Alberta Brigham and Women's Hospital Board of the Swiss Federal Institutes of Technology

About

J. Zimmermann is an author at Novartis (Switzerland) specializing in natural sciences, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	16	17	2.3K
2	Biochemistry	15	15	2.2K
3	Medicine	12	13	5.8K
4	Engineering	9	9	495
5	Biomolecular Engineering	8	8	505

J. Zimmermann

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells Brian Druker, Shu Tamura, Elisabeth Buchdunger, Nature Medicine Signal TransductionCell RegulationAbl Tyrosine KinaseMedicineReceptor Tyrosine Kinase	1996	3.6K
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Elisabeth Buchdunger, J. Zimmermann, Helmut Mett, PubMed Abl Protein-tyrosine KinaseCellular PharmacologyPharmacotherapyAbl ProteinsPharmaceutical Chemistry	1996	1.1K
CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins Martin Carroll, Sayuri Ohno-Jones, Shu Tamura, Blood	1997	520
CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins Martin Carroll, Sayuri Ohno-Jones, Shu Tamura, Blood	1997	446
RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Elisabeth Buchdunger, J. Zimmermann, Helmut Mett, Proceedings of the National Academy of Sciences ImmunologyCell GrowthSignaling PathwayReceptor Tyrosine KinaseCgp 53716	1995	269
Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives J. Zimmermann, Elisabeth Buchdunger, Helmut Mett, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryDerivativesBiochemistryMedicine	1997	242
Phenylamino-pyrimidine (PAP) — derivatives: a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitors J. Zimmermann, Elisabeth Buchdunger, Helmut Mett, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1996	144
(+)‐11,11′‐Di‐<i>O</i>‐methylelaiophylidene – preparation from elaiophylin and total synthesis from (<i>R</i>)‐3‐hydroxybutyrate and (<i>S</i>)‐malate Dieter Seebàch, Hak‐Fun Chow, Richard F. W. Jackson, Liebigs Annalen der Chemie Bioorganic ChemistryEngineeringOrganic ChemistryMedicinal ChemistryDiversity Oriented Synthesis	1986	100
Brominations of Cyclic Acetals from α‐Amino Acids and α‐ or β‐Hydroxy Acids with <i>N</i>‐Bromosucinimide J. Zimmermann, Dieter Seebàch Helvetica Chimica Acta EngineeringOrganic ChemistryChemistryMedicinal ChemistryDiversity Oriented Synthesis	1987	94
An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library Design Ansgar Schuffenhauer, J. Zimmermann, Ruedi Stoop, Journal of Chemical Information and Computer Sciences Drug TargetBioorganic ChemistryAnnotation EffortsChemical BiologyBioinformatics Database	2002	94

Page 1